Transbiohope | BIOHOPE
Transbio project, oriented to the development of an in vitro diagnostic kit for the treatment of chronic rejection with immunosuppressants. H2020 program of the European Union
"trasplante riñón” “diagnóstico in vitro” “in vitro diagnosis” “trasplante renal” “H2020” “European Commission project” “renal transplant” “kidney transplant” “start-up” “Tres Cantos” “biomedicina” “biomedicine” “biotechnology” “immunobiogram” “inmunobiograma” “tratamiento inmunosupresores” “Treatment with immunosuppressants”
13396
page-template-default,page,page-id-13396,page-parent,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

WHAT WE DO

Biohope Ltd. is a biomedical company focused in the research and development of novel solutions, to personalize and optimize the clinical management of chronic inflammation in patients under treatment with immunosuppressive and/or immunomodulatory therapies.

CORE GOALS

To facilitate medical doctors to personalize and optimize the medical treatment in their patients with organ transplantation and rheumatoid arthritis.

To market INMUNOBIOGRAM as a simple & highly scalable technology easy to use.

Start worldwide sales from 2020

Create a highly motivating and creative company environment.

WE ARE
ON PLAN

Biohope is a fast-growing company that has achieved significant goals in less than three years of existence, and we keep on moving!

INMUNOBIOGRAM R+D Plan

RENAL TRANSPLANTATION. Biohope has successfully finished a National Study (BH-Pilot). We work with 8 top-class Transplant Units of 4 EU countries and MGH (Harvard School of Medicine) in an International Multicenter clinical Study

RHEUMATOID ARTHRITIS. Biohope is initiating a national study to adapt the Inmunobiogram® technology to this new indication.

INMUNOBIOGRAM Patents

We have applied for several EU patents and PCT for the technology under our bioassay INMUNOBIOGRAM, and we expect the project will deliver further industrial property.

ORGANIZATIONS

The National Transplant Organization of Spain, the most renowned transplant organization in Europe, supported this project to be scaled up to European scope. We also have been offered support to the project from 5 Public Administration entities.

INMUNOBIOGRAM-Regulatory and Product Development

Functional prototype and user interface ongoing. Quality Assurance System (ISO 13485) in progress to obtain CE Mark. FDA approval follows 510 K pathway.